Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sumitomo Chemical Co ( (JP:4005) ) has shared an announcement.
Sumitomo Chemical Co., Ltd. has completed a company split and share transfer involving its subsidiary, Sumitomo Pharma Co., Ltd., transferring 60% of its new Asian business subsidiary to Marubeni Global Pharma Inc. This strategic move is expected to generate approximately 45 billion yen in other operating income for Sumitomo Chemical, which will be used to strengthen its financial foundation and focus on growth initiatives.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen430.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
More about Sumitomo Chemical Co
Sumitomo Chemical Co., Ltd. operates in the chemical industry, focusing on a range of products and services including pharmaceuticals through its subsidiary, Sumitomo Pharma Co., Ltd. The company is listed on the Prime Section of the Tokyo Stock Exchange.
Average Trading Volume: 8,916,077
Technical Sentiment Signal: Buy
Current Market Cap: Yen611.1B
See more insights into 4005 stock on TipRanks’ Stock Analysis page.